跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-ROSUVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-ROSUVASTATIN
Authorized
STANDARD
M-ROSUVASTATIN
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9ce61828958c07ea
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
9ce61828958c07ea
Drug Approval Canada Name
M-ROSUVASTATIN
Product Name
M-ROSUVASTATIN
Status
Marketed
Status Date
2024-02-28
Original Market Date
2020-08-25
Din
02496542
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.08
Atc Original
C10AA07 ROSUVASTATIN
Atc Name
c 10 aa 07
Aig Number
0148963001
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
ROSUVASTATIN (ROSUVASTATIN CALCIUM)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9ce61828958c07ea
Type
Standard
Back to Health Canada Approvals